The reason raised those questions were especially after what happened to opthea … I was lucky enough to question their study design and get out when they were on a high post $1…
the same goes for dimerix , it’s nice to see how far they have come but personally I’m not convinced ..yet and I cashed out when they were on a high in thr 60 cents.
i put all the cash from opt and Dxb into alterity. I’m convinced now without a doubt the drug is doing something. If th. ey had statistical significance I wouldn’t be posting anything, you can be rest assured. All I want is some sort of a dummy I can pacify myself with .
even if they get AA subject to a phase 3, I don’t think I will rest easy. There are heaps of drugs out there that have failed post AA because phase 3 wasn’t successful.
if we Goto a phase 3, I for one want to know what their new endpoints are and why they chose them based on phase 2b.
my 2 cents dyor
ATH Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)